Main content

Contributors:

Date created: | Last Updated:

: DOI | ARK

Creating DOI. Please wait...

Create DOI

Category: Project

Wiki

Rationale and objectives

  • The rapidly expanding knowledge in genomics, proteomics, and transcriptomics has led to the discovery of new molecular alterations and markers of immune phenotypes shared by multiple tumor types regardless of their site of origin [1]. Since 2017, the Food and Drug Administration (FDA) has approved six anticancer agents with a "histology-agnostic" indication: two immune c…

Files

Files can now be accessed and managed under the Files tab.

Citation

Recent Activity

Unable to retrieve logs at this time. Please refresh the page or contact support@osf.io if the problem persists.

OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.
Accept
×

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.